검색
Akoustis Technologies Ord Shs
AKTS관심 목록에 추가
21.880USD
-0.980-4.29%
종가 09-18 16:00（ET）
1.21B시가총액
손실P/E TTM
자세한 내용은 Akoustis Technologies Ord Shs 회사
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Akoustis Technologies Ord Shs 프로필
종목 코드 AKTS
회사 이름Aktis Oncology Inc
상장일Jan 09, 2026
CEORoden (Matthew)
직원 수117
유형Ordinary Share
회계 연도 종료Jan 09
주소17 Drydock Avenue
도시BOSTON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02210
전화13026587581
웹사이트https://www.aktisoncology.com/
종목 코드 AKTS
상장일Jan 09, 2026
CEORoden (Matthew)
Akoustis Technologies Ord Shs의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Matthew (Matt) Roden, Ph.D.
Dr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Dr. Matthew (Matt) Roden, Ph.D.
Dr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Dr. Paul L. Feldman, Ph.D.
Dr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board
Chairman of the Board
--
-100.00%
Ms. Shulamit Ron-Bigger, Ph.D.
Ms. Shulamit Ron-Bigger, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kyle D. Kuvalanka
Mr. Kyle D. Kuvalanka
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Akos Czibere, M.D., Ph.D.
Mr. Akos Czibere, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Ken Herrmann, M.D.
Mr. Ken Herrmann, M.D.
Independent Director
Independent Director
--
--
Mr. Lloyd M. Segal
Mr. Lloyd M. Segal
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Matthew (Matt) Roden, Ph.D.
Dr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Dr. Matthew (Matt) Roden, Ph.D.
Dr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Dr. Paul L. Feldman, Ph.D.
Dr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board
Chairman of the Board
--
-100.00%
Ms. Shulamit Ron-Bigger, Ph.D.
Ms. Shulamit Ron-Bigger, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
자주 묻는 질문
Akoustis Technologies Ord Shs의 상위 5대 주주는 누구인가요?
Akoustis Technologies Ord Shs의 상위 5대 주주는 다음과 같습니다: Dr. Matthew (Matt) Roden, Ph.D.
Akoustis Technologies Ord Shs(AKTS)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Akoustis Technologies Ord Shs의 주식을 보유한 기관은 총 195곳이며, 이들이 보유한 주식의 총 가치는 약 27.52M로 전체 발행 주식의 51.47%를 차지합니다. 이는 2025Q4 대비 1127277.00 증가한 수치입니다.